{"id":"NCT01047683","sponsor":"Amarin Pharma Inc.","briefTitle":"Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL","officialTitle":"Evaluation of the Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride Levels ≥ 500 mg/dL and ≤ 2000 mg/dL","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12","primaryCompletion":"2010-10","completion":"2011-07","firstPosted":"2010-01-13","resultsPosted":"2022-04-25","lastUpdate":"2022-04-25"},"enrollment":229,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertriglyceridemia"],"interventions":[{"type":"DRUG","name":"AMR101 (ethyl icosapentate) - 4 g/day","otherNames":["VASCEPA® (icosapent ethyl)"]},{"type":"DRUG","name":"AMR101 (ethyl icosapentate) - 2 g/day","otherNames":["VASCEPA® (icosapent ethyl)"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"AMR101 (ethyl icosapentate) - 2 g/day","type":"EXPERIMENTAL"},{"label":"AMR101 (ethyl icosapentate) - 4 g/day","type":"EXPERIMENTAL"}],"summary":"The primary objective is to determine the efficacy of AMR101 (ethyl icosapentate) compared to placebo in lowering fasting triglyceride levels in patients with very high fasting triglyceride levels ≥ 500 and ≤ 2000 mg/dL.","primaryOutcome":{"measure":"Difference Between AMR101 (Ethyl Icosapentate) and Placebo Treatment Groups in Triglyceride Lowering Effect","timeFrame":"baseline and 12 weeks","effectByArm":[{"arm":"AMR101 (Ethyl Icosapentate) - 2 g/Day","deltaMin":-7,"sd":null},{"arm":"AMR101 (Ethyl Icosapentate) - 4 g/Day","deltaMin":-26.6,"sd":null},{"arm":"Placebo","deltaMin":9.7,"sd":null}],"pValues":[{"comp":"OG001 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"0.0051"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":60,"countries":["United States","Denmark","Finland","Germany","India","Italy","Mexico","Netherlands","Russia","South Africa","Ukraine"]},"refs":{"pmids":["21683321","23312052","23325450","23992935","25893544","27206952","27596132","27418543","27939227"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":76},"commonTop":["Diarrhea","Nausea","Eructation"]}}